Literature DB >> 10094204

High-efficiency transfer of cystic fibrosis transmembrane conductance regulator cDNA into cystic fibrosis airway cells in culture using lactosylated polylysine as a vector.

W J Kollen1, A E Mulberg, X Wei, M Sugita, V Raghuram, J Wang, J K Foskett, M C Glick, T F Scanlin.   

Abstract

To find more efficient vectors for the transfer of CFTR cDNA, lactosylated polylysine was explored for transfer into airway epithelial cells in primary culture. The efficacy and high efficiency of transfection were shown by several criteria: expression of both mRNA and protein for CFTR and the functional correction of the Cl- channel activity. Using specific combinations of agents to enhance the transfection, an efficiency of 90% was obtained as detected by in situ hybridization with digoxigenin-labeled probes generated against exon 14 of CFTR. The highest efficiency was observed by adding E5CA peptide (10 microg) and 5% glycerol to the transfection mixture. The degree of transfection could be controlled by the enhancing agents, thus modulating the efficiency of transfection. The highest level of transfection efficiency is equivalent to that reported for viral vectors. None of the agents or their combinations in the concentrations used were cytotoxic to the primary cells. Antibody pAb3145 was used to detect the expression of the CFTR protein in the cells. When an N-terminal GFP-CFTR fusion gene was used to transfect the CF cells a functional correction of the CFTR Cl- channel was detected by patch-clamp electrophysiology. The high efficiency of CFTR gene transfer with lactosylated polylysine leads to the conclusion that lactosylated polylysine is a promising vector to transfer the CFTR gene into human airway cells in culture.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094204     DOI: 10.1089/10430349950018689

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  11 in total

1.  Gene therapy for cancer: current status and prospects.

Authors:  Gregory P Kouraklis
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

Review 2.  Gene therapy: light is finally in the tunnel.

Authors:  Huibi Cao; Robert S Molday; Jim Hu
Journal:  Protein Cell       Date:  2012-01-10       Impact factor: 14.870

3.  Terminal glycosylation of cystic fibrosis airway epithelial cells.

Authors:  A D Rhim; V A Kothari; P J Park; A E Mulberg; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

Review 4.  Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose.

Authors:  D T Klink; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 5.  Terminal glycosylation and disease: influence on cancer and cystic fibrosis.

Authors:  T F Scanlin; M C Glick
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

6.  Novel adenoviral vectors coding for GFP-tagged wtCFTR and deltaF508-CFTR: characterization of expression and electrophysiological properties in A549 cells.

Authors:  Horia Vais; Guang-Ping Gao; Michael Yang; Phoi Tran; Jean-Pierre Louboutin; Suryanarayan Somanathan; James M Wilson; William W Reenstra
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

7.  GFP-tagged CFTR transgene is functional in the G551D cystic fibrosis mouse colon.

Authors:  D Oceandy; B McMorran; R Schreiber; B J Wainwright; K Kunzelmann
Journal:  J Membr Biol       Date:  2003-04-01       Impact factor: 1.843

Review 8.  Lipid Nanoparticles for Ocular Gene Delivery.

Authors:  Yuhong Wang; Ammaji Rajala; Raju V S Rajala
Journal:  J Funct Biomater       Date:  2015-06-08

9.  Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo.

Authors:  Ammaji Rajala; Yuhong Wang; Ye Zhu; Michelle Ranjo-Bishop; Jian-Xing Ma; Chuanbin Mao; Raju V S Rajala
Journal:  Nano Lett       Date:  2014-08-12       Impact factor: 11.189

Review 10.  Recent Advancements in Gene Therapy for Hereditary Retinal Dystrophies.

Authors:  Ayşe Öner
Journal:  Turk J Ophthalmol       Date:  2017-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.